Consensus document and recommendations on the use of natriuretic peptides in clinical practice

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Revista Clinica Espanola

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.RCENG.2016.04.001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Head-to-head comparison of 10 natriuretic peptide assays

  2015cited by this paper
• The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting

  2015cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis

  2011cited by this paper
• Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.

  2011cited by this paper
• B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.

  2010cited by this paper
• Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.

  2009cited by this paper
• Improving the diagnosis of acute heart failure using a validated prediction model.

  2009cited by this paper
• Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.

  2008cited by this paper
• Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.

  2008cited by this paper
• Amino-terminal pro-B-type natriuretic peptide: analytic considerations.

  2008cited by this paper
• Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea.

  2008cited by this paper
• Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients.

  2008cited by this paper
• N-Terminal Pro–B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure: Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study

  2007cited by this paper
• Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea.

  2006cited by this paper
• Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.

  2006cited by this paper
• Long-term clinical variation of NT-proBNP in stable chronic heart failure patients.

  2006cited by this paper
• NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.

  2006cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

  2005cited by this paper
• [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure].

  2005cited by this paper
• The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study

  2005cited by this paper
• NTproBNP circulante, un nuevo biomarcador para el diagnóstico del paciente con disnea aguda

  2005cited by this paper
• Utilidad del NTproBNP en el manejo urgente del paciente con disnea severa y diagnóstico dudoso de insuficiencia cardíaca

  2005cited by this paper
• Usefulness of NTproBNP in the Emergency Management of Patients With Severe Dyspnea and an Uncertain Heart Failure Diagnosis

  2005cited by this paper
• N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients

  2004cited by this paper
• Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial.

  2003cited by this paper
• Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.

  2003cited by this paper
• Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

  2002cited by this paper
• B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure: Analysis From Breathing Not Properly (BNP) Multinational Study

  2002cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure.

  2001cited by this paper
• Molecular Biology of the Natriuretic Peptides and Their Receptors

  1992cited by this paper

• Cardiovascular biomarkers and preeclampsia: A narrative review

  2025cites this paper
• Study protocol for an observational cohort evaluating incidence and clinical relevance of perioperative elevation of high-sensitivity troponin I and N-terminal pro-brain natriuretic peptide in patients undergoing lung resection

  2022cites this paper
• NT-proBNP as predictor factor of cardiotoxicity during trastuzumab treatment in breast cancer patients

  2020cites this paper
• NOVICA: Characteristics and outcomes of patients who have a first episode of heart failure (de novo)

  2019cites this paper
• NOVICA: características y evolución en los pacientes que presentan un primer episodio de insuficiencia cardiaca (de novo)

  2019cites this paper
• Hospitalización: el momento más vulnerable

  2019cites this paper
• Evolution of the clinical profile of patients with acute heart failure treated in Spanish emergency departments

  2017cites this paper
• Evolution of the clinical profile of patients with acute heart failure treated in Spanish emergency departments.

  2017cites this paper
• Magnitudes biológicas que tiene interés medir de modo urgente

  2017cites this paper
• A Case Base View of Heart Failure Predisposition Risk

  2017cites this paper